- $5.69bn
- $5.74bn
- $1.88bn
- 70
- 56
- 62
- 68
Annual income statement for RLI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Total Premiums Earned | |||||
| Net Investment Income | |||||
| Realized & Unrealized Gains / Losses | |||||
| Total Revenue | 1,179 | 1,698 | 1,512 | 1,770 | 1,882 |
| Losses, Benefits, and Adjustments | |||||
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 864 | 979 | 1,137 | 1,332 | 1,367 |
| Operating Profit | 315 | 719 | 375 | 439 | 515 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 344 | 721 | 377 | 428 | 506 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 279 | 583 | 305 | 346 | 403 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 279 | 583 | 305 | 346 | 403 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 279 | 583 | 305 | 346 | 403 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.53 | 3.18 | 1.65 | 1.87 | 4.37 |
| Dividends per Share | |||||
| Special Dividends per Share |